Mettler-Toledo International, Inc. (NYSE:MTD) Receives Consensus Rating of “Hold” from Analysts

Shares of Mettler-Toledo International, Inc. (NYSE:MTD) have been assigned an average recommendation of “Hold” from the thirteen ratings firms that are currently covering the stock, MarketBeat Ratings reports. Eight analysts have rated the stock with a hold recommendation and five have issued a buy recommendation on the company. The average 1 year price target among analysts that have issued a report on the stock in the last year is $1,419.5455.

A number of brokerages have weighed in on MTD. Citigroup upped their price target on Mettler-Toledo International from $1,600.00 to $1,700.00 and gave the company a “buy” rating in a research report on Monday, November 10th. Evercore ISI boosted their target price on shares of Mettler-Toledo International from $1,275.00 to $1,400.00 and gave the company an “outperform” rating in a research note on Tuesday, October 7th. Stifel Nicolaus upped their target price on shares of Mettler-Toledo International from $1,450.00 to $1,600.00 and gave the stock a “buy” rating in a report on Monday, November 10th. Barclays increased their target price on shares of Mettler-Toledo International from $1,350.00 to $1,600.00 and gave the stock an “overweight” rating in a research report on Monday, November 10th. Finally, Bank of America boosted their price target on shares of Mettler-Toledo International from $1,260.00 to $1,390.00 and gave the company a “neutral” rating in a research report on Monday, September 22nd.

Mettler-Toledo International Stock Down 0.7%

NYSE MTD opened at $1,413.49 on Friday. Mettler-Toledo International has a twelve month low of $946.69 and a twelve month high of $1,525.17. The stock has a market cap of $28.88 billion, a P/E ratio of 35.25, a PEG ratio of 4.60 and a beta of 1.40. The company’s 50-day simple moving average is $1,389.11 and its 200 day simple moving average is $1,283.10.

Mettler-Toledo International (NYSE:MTD) last released its quarterly earnings data on Thursday, November 6th. The medical instruments supplier reported $11.15 earnings per share for the quarter, beating analysts’ consensus estimates of $10.62 by $0.53. Mettler-Toledo International had a negative return on equity of 426.96% and a net margin of 21.20%.The company had revenue of $1.03 billion for the quarter, compared to the consensus estimate of $997.36 million. During the same period in the previous year, the business earned $10.21 earnings per share. The company’s quarterly revenue was up 7.9% on a year-over-year basis. Mettler-Toledo International has set its Q4 2025 guidance at 12.680-12.880 EPS and its FY 2025 guidance at 42.050-42.250 EPS. Research analysts anticipate that Mettler-Toledo International will post 42.71 earnings per share for the current year.

Insiders Place Their Bets

In other Mettler-Toledo International news, insider La Guerroniere Marc De sold 6,880 shares of Mettler-Toledo International stock in a transaction on Tuesday, November 11th. The stock was sold at an average price of $1,450.00, for a total value of $9,976,000.00. Following the completion of the transaction, the insider owned 187 shares in the company, valued at approximately $271,150. The trade was a 97.35% decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, CEO Patrick Kaltenbach sold 2,000 shares of the stock in a transaction on Wednesday, November 12th. The stock was sold at an average price of $1,462.50, for a total value of $2,925,000.00. Following the sale, the chief executive officer owned 3,670 shares in the company, valued at $5,367,375. The trade was a 35.27% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders sold 19,565 shares of company stock worth $28,683,737 over the last ninety days. 1.94% of the stock is owned by insiders.

Institutional Inflows and Outflows

Institutional investors and hedge funds have recently added to or reduced their stakes in the stock. Allworth Financial LP grew its holdings in Mettler-Toledo International by 6.1% during the 3rd quarter. Allworth Financial LP now owns 121 shares of the medical instruments supplier’s stock worth $149,000 after acquiring an additional 7 shares during the last quarter. IFP Advisors Inc lifted its position in shares of Mettler-Toledo International by 23.3% during the third quarter. IFP Advisors Inc now owns 111 shares of the medical instruments supplier’s stock worth $136,000 after purchasing an additional 21 shares in the last quarter. Swiss Life Asset Management Ltd lifted its position in shares of Mettler-Toledo International by 13.5% during the third quarter. Swiss Life Asset Management Ltd now owns 3,950 shares of the medical instruments supplier’s stock worth $4,849,000 after purchasing an additional 470 shares in the last quarter. Investment Research Partners LLC bought a new stake in shares of Mettler-Toledo International during the third quarter valued at approximately $654,000. Finally, CIBC Bancorp USA Inc. acquired a new stake in shares of Mettler-Toledo International in the third quarter valued at approximately $3,496,000. Institutional investors and hedge funds own 95.07% of the company’s stock.

Mettler-Toledo International Company Profile

Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company’s laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.